Dr Reddy’s signs in-licensing pact with Ingenus Pharmaceuticals for cancer treatment injection

New Delhi, June 12, 2024. Dr Reddy’s Laboratories Ltd on Wednesday said it has signed a licensing pact with US-based Ingenus Pharmaceuticals, LLC, to commercialise Cyclophosphamide injection used in treatment of cancer. The company’s wholly-owned subsidiary Dr Reddy’s Laboratories Inc and Ingenus Pharmaceuticals, LLC have entered into license agreement, Dr Reddy’s Laboratories Ltd (DRL) said…

Read More